Orbimed Advisors LLC, 10% Owner at Enliven Therapeutics, Inc. (ELVN), sold 860,123 shares at $45.38 ($39.0M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Open-market sale of $39.0M ELVN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 1,477 | $66K | 0.2% |
| 2 | $45.00 | 46,776 | $2.1M | 5.4% |
| 3 | $45.38 | 24,846 | $1.1M | 2.9% |
| 4 | $45.38 | 787,024 | $35.7M | 91.5% |
| Total | $45.36 avg | 860,123 | $39.0M | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |